Rheumatologists and the Requesting of Antinuclear Antibodies (ANA) Tests in Patients With Rheumatologic Complaints

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

29 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the effect of a simple intervention (a combination of education and feedback) on Antinuclear Antibody (ANA) testing.

This aim was chosen because of the known overuse of many laboratory tests, of which ANA testing is one. As overuse of ANA tests can have negative consequences (both for patients and society), the investigators designed an intervention to see how this would influence Antinuclear Antibody testing by rheumatologists.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Improving Beliefs About Medication in Patients With Rheumatoid Arthritis

NCT00968266

Musculoskeletal Diseases Rheumatoid Arthritis

COMPLETED NA

Medication Adherence in Rheumatic Diseases

NCT06018350

Chronic Rheumatic Diseases

COMPLETED NA

Study of Some Risk Factors for Developing RA

NCT03624179

Rheumatoid Arthritis

UNKNOWN

The Predictive Value of Ultrasound in Early Rheumatoid Arthritis

NCT01752309

Rheumatoid Arthritis Predictive Value of Ultrasound in Early Rheumatoid Arthritis

COMPLETED

Diagnostic Value of Anti-MCV in Pts With RA

NCT03265236

Anti-MCV in Rheamatoid Arthritis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Education and feedback

The intervention consisted of a one-hour, small group educational session. During this session information on rational ANA testing was provided and feedback on current ANA testing was provided to the rheumatologists. A booster session with the same components was held 6 months after the first session.

Group Type EXPERIMENTAL

Education and feedback

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Education and feedback

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* rheumatologists who are consulting patients at the rheumatology outpatient clinic of a participating centre

Exclusion Criteria

* rheumatologists not working the full study period (pre- and post-intervention) at a participating centre
* rheumatologists not giving their consent to participate

\- patients with an ANA test requested during a clinical admission

Eligible Sex

ALL

Accepts Healthy Volunteers

No